drugset / Trial / NCT06430125

Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus

NCT06430125

Phase 3 Unknown 46 enrolled Tanta University
RandomizedParallel-groupOpen-labelPrevention

Summary

This study aims to evaluate the possible nephroprotective effect of nicorandil in patients with type 2 diabetes mellitus .

Timeline

Start
2023-02-28
Primary completion
2025-02
Completion
2025-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicorandil Other / unclassified 10 mg Oral